Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
News on Dr Reddys Laboratories
Hold Dr Reddys Labs for long term: Mehta
3.08 pm | 23 Dec 2010 | Source: CNBC-TV18
Dr Reddys Labs is expected to grow at rate of around 26-27% in next 2-3 years. ROEs on capital employed would be around 22-23% and its fairly valued a...
Hold Dr Reddys Labs: Paul
3.05 pm | 23 Dec 2010 | Source: CNBC-TV18
As long as supports close to Rs 1575-1550 holds, Dr Reddys Labs is very likely to bounce back. Whether it takes out Rs 1800-1775 need to see. If one h...
Dr Reddy's Labs may come down: Gupta
5.16 pm | 22 Dec 2010 | Source: CNBC-TV18
Dr Reddy Labs certainly had a very tragic event. It should have a fairly significant downside impact on the stock, says Radhika Gupta of Forefront Cap...
Dr Reddy's in licensing deal with Russian firm
8.34 pm | 21 Dec 2010 | Source: Reuters
Dr. Reddy's Laboratories said on Tuesday it has signed an agreement with Russia's R-Pharm for licensing, technology transfer, manufacturing and market...
Dr Reddy's buys Glaxo's US penicillin business
8.33 am | 24 Nov 2010 | Source: Reuters
GlaxoSmithKline is getting out of the oral penicillin business in the United States, selling a factory and two key brands to India's Dr. Reddy's Labor...
Quick Links for Dr Reddys Laboratories
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.